Key result
Levosimendan infusion was comparable to intra-aortic balloon pump in improving hemodynamics and resulted in reduced transfusion requirements and a shorter ICU stay in high-risk CABG patients.
Why the study?
Preoperative left ventricular dysfunction is associated with adverse perioperative outcomes, and while IABP improves outcomes, balloon installation carries disadvantages, prompting comparison with levosimendan.
Does levosimendan improve clinical and hemodynamic outcomes compared to intra-aortic balloon pump in patients with LVEF <35% undergoing CABG?
RCT (n=60)
randomized
Does levosimendan improve clinical and hemodynamic outcomes compared to intra-aortic balloon pump in patients with LVEF <35% undergoing CABG?
Answers are grounded in this paper and cite their sources.
In patients with LVEF <35% undergoing CABG, levosimendan is a viable alternative to IABP, offering comparable hemodynamic support with the added benefits of shorter ICU stays and reduced transfusion requirements.
Background: Preoperative left ventricular dysfunction is an independent risk factor for perioperative mortality and morbidity and is also associated with postoperative low cardiac output syndrome. IABP improved outcomes in high-risk cardiac patients. However, installation of the balloon has many disadvantages. Recently, a new drug named Levosimendan is commonly used as an inotropic support. it does not increase oxygen demand of myocardium.Aim of the work: The purpose of our study was to compare the efficiency of levosimendan versus intra-aortic balloon pump in patients with poor left ventricular function undergoing coronary artery bypass grafting (CABG) with ejection fraction less than 35%.Patients and Methods: sixty patients were randomized into 2 groups, according to the treatment they received - either levosimendan (Group A) or intra-aortic balloon counter pulsation (Group B). and compared with respect to The use of inotropic drugs, weaning from CPB, Hemodynamics, transfusion requirements, ICU stay, hospital stay and in-hospital mortality.Results: There were no differences in preoperative characteristics including patients’ age, sex, BMI, and comorbidities. The Levosemindan group had reduced transfusion requirements and shorter ICU stay as compared to IABP group.Conclusion: levosimendan infusion after induction of anesthesia is a good choice with an acceptable option in comparison to IABP. The use of levosimendan in high-risk cardiac patients is comparable to IABP in improving hemodynamics during and after conventional on-pump CABG and results in a shorter ICU stay.
No takes yet. Share an insight, caveat, or question.
Azzab et al. (2021) conducted an RCT in Poor left ventricular function undergoing CABG (n=60). Levosimendan vs. Intra-aortic balloon pump (IABP) was evaluated on Use of inotropic drugs, weaning from CPB, hemodynamics, transfusion requirements, ICU stay, hospital stay and in-hospital mortality. Levosimendan infusion was comparable to intra-aortic balloon pump in improving hemodynamics and resulted in reduced transfusion requirements and a shorter ICU stay in high-risk CABG patients.
Synapse has enriched 10 related papers. Consider them for comparative context: